Menu
Back to Journals » OncoTargets and Therapy » Volume 17
Case report
MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,030 | Dovepress* | 1,030+ | 27 | 1,057 | |
| Totals | 1,030 | 27 | 1,057 | ||
| *Since 9 April 2024 | |||||
View citations on PubMed Central and Google Scholar